中文名 | 2-氯-4-甲氧基-5-氨基嘧啶 |
---|---|
英文名 | 2-Chloro-4-methoxy-5-pyrimidinamine |
英文别名 |
5-amino-2-chloro-1-methyl-1H-benzimidazole
2-chloro-1-methyl-1H-benzoimidazol-5-ylamine 2-chloropyrimidine-5-ylamine 5-Amino-2-chloropyrimidine 2-CHLORO-5-AMINOPYRIMIDINE 1-methyl-2-chloro-5-aminobenzimidazole 2-chloro-4-methoxypyrimidine-5-ylamine 5-amino-2-chloro-4-methoxypyrimidine 2-Chlor-pyrimidin-5-ylamin 2-chloro-4-methoxypyrimidin-5-amine 2-chloropyrimidin-5-ylamine |
分子式 | C5H6ClN3O |
---|---|
分子量 | 159.57400 |
精确质量 | 159.02000 |
PSA | 61.03000 |
LogP | 1.30200 |
储存条件 | 2-8°C |
~89% 96833-41-9 |
文献:CANCER RESEARCH TECHNOLOGY LIMITED; Bavetsias, Vassilios; Atrash, Butrus; Naud, Sébastien Gaston André; Sheldrake, Peter William; Blagg, Julian Patent: US2013/345181 A1, 2013 ; Location in patent: Paragraph 0785 ; |
~88% 96833-41-9 |
文献:CANCER RESEARCH TECHNOLOGY LIMITED; BAVETSIAS, Vassilios; ATRASH, Butrus; NAUD, Sebastien Gaston Andre; SHELDRAKE, Peter William; BLAGG, Julian Patent: WO2012/123745 A1, 2012 ; Location in patent: Page/Page column 117 ; WO 2012/123745 A1 |
~% 96833-41-9 |
文献:Zeneca Limited Patent: US5861401 A1, 1999 ; |